Literature DB >> 18377476

Congenital heart defects and fetal alcohol spectrum disorders.

Larry Burd1, Eric Deal, Rodrigo Rios, Edward Adickes, Joshua Wynne, Marilyn G Klug.   

Abstract

OBJECTIVE: Review of the prevalence of congenital heart defects (CHD) and fetal alcohol spectrum disorder (FASD).
DESIGN: We conducted a search of the Medline and Pubmed databases to identify papers reporting the association. We then searched the reference lists of the papers and reference books for additional sources.
RESULTS: We found 29 studies that met our inclusion criteria. In the 12 case series studies of subjects with FASD, the proportion of cases with a CHD (atrial [ASD] and ventricular [VSD] septal defects, other defects, or unspecified CHD) ranged from 33% to 100%. From the 14 retrospective studies, the rate of septal defects was 21%, other structural defects 6% and unspecified defects was 12%. For the 2 case-control studies, the odds of CHD ranged from 1.0 (subjects with fetal alcohol effect) to 18.0 (subjects with fetal alcohol syndrome). In the 1 prospective study of CHD the OR for a child to have CHD and FASD was 1.0. KEY
CONCLUSION: Pediatric cardiologists may have frequent contact with children with FASD and increased levels of attention to prenatal alcohol exposure as a potential etiology of CHD is indicated.

Entities:  

Mesh:

Year:  2007        PMID: 18377476     DOI: 10.1111/j.1747-0803.2007.00105.x

Source DB:  PubMed          Journal:  Congenit Heart Dis        ISSN: 1747-079X            Impact factor:   2.007


  41 in total

1.  Multiplexed digital quantification of binge-like alcohol-mediated alterations in maternal uterine angiogenic mRNA transcriptome.

Authors:  Jayanth Ramadoss; Ronald R Magness
Journal:  Physiol Genomics       Date:  2012-04-24       Impact factor: 3.107

2.  N-Acetylcysteine prevents the decreases in cardiac collagen I/III ratio and systolic function in neonatal mice with prenatal alcohol exposure.

Authors:  Van K Ninh; Elia C El Hajj; Martin J Ronis; Jason D Gardner
Journal:  Toxicol Lett       Date:  2019-08-16       Impact factor: 4.372

Review 3.  Epigenetic mechanisms in alcohol- and adversity-induced developmental origins of neurobehavioral functioning.

Authors:  K E Boschen; S M Keller; T L Roth; A Y Klintsova
Journal:  Neurotoxicol Teratol       Date:  2018-01-02       Impact factor: 3.763

4.  Fetal regional brain protein signature in FASD rat model.

Authors:  Katie L Davis-Anderson; Hendrik Wesseling; Lara M Siebert; Emilie R Lunde-Young; Vishal D Naik; Hanno Steen; Jayanth Ramadoss
Journal:  Reprod Toxicol       Date:  2018-02-01       Impact factor: 3.143

5.  Complex cardiac defects after ethanol exposure during discrete cardiogenic events in zebrafish: prevention with folic acid.

Authors:  Swapnalee Sarmah; James A Marrs
Journal:  Dev Dyn       Date:  2013-09-02       Impact factor: 3.780

6.  Placental Proteomics Reveal Insights into Fetal Alcohol Spectrum Disorders.

Authors:  Katie L Davis-Anderson; Sebastian Berger; Emilie R Lunde-Young; Vishal D Naik; Heewon Seo; Greg A Johnson; Hanno Steen; Jayanth Ramadoss
Journal:  Alcohol Clin Exp Res       Date:  2017-08-09       Impact factor: 3.455

7.  Performance measurement: a proposal to increase use of SBIRT and decrease alcohol consumption during pregnancy.

Authors:  Peggy L O'Brien
Journal:  Matern Child Health J       Date:  2014-01

8.  Chronic binge alcohol exposure during pregnancy impairs rat maternal uterine vascular function.

Authors:  Kaviarasan Subramanian; Vishal D Naik; Kunju Sathishkumar; Chandrashekar Yallampalli; George R Saade; Gary D Hankins; Jayanth Ramadoss
Journal:  Alcohol Clin Exp Res       Date:  2014-06-24       Impact factor: 3.455

9.  Alcohol-induced alterations in maternal uterine endothelial proteome: a quantitative iTRAQ mass spectrometric approach.

Authors:  Jayanth Ramadoss; Ronald R Magness
Journal:  Reprod Toxicol       Date:  2012-09-05       Impact factor: 3.143

10.  ALDH1A2 (RALDH2) genetic variation in human congenital heart disease.

Authors:  Marilene Pavan; Viviane F Ruiz; Fábio A Silva; Tiago J Sobreira; Roberta M Cravo; Michelle Vasconcelos; Lívia P Marques; Sonia M F Mesquita; José E Krieger; Antônio A B Lopes; Paulo S Oliveira; Alexandre C Pereira; José Xavier-Neto
Journal:  BMC Med Genet       Date:  2009-11-03       Impact factor: 2.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.